Molecular biology reports · 2026
Boldine enhances hyperthermia-induced apoptosis in AGS gastric cancer cells in association with attenuation of the HSF1-HSP stress response.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ahn Chae Ryeong, Baek Seung Ho
Аннотация
BACKGROUND: Gastric cancer presents therapeutic challenges owing to treatment resistance and stress adaptation. This study investigated whether boldine enhances mild hyperthermia-induced cytotoxicity in AGS gastric cancer cells and evaluated its association with attenuation of the heat shock response involving heat shock proteins (HSPs) and heat shock factor 1 (HSF1).
METHODS AND RESULTS: AGS cells were pretreated with boldine (1 h) and exposed to 37-43 °C (30 min). Combined treatment reduced viability, wound closure, and colony formation more than single treatments. The apoptotic fraction increased from 8.08% in untreated controls to 28.79% with boldine alone and 3.55% with hyperthermia alone, reaching 46.33% after cotreatment. Cotreatment altered cell cycle distribution (S and G2/M fractions), increased reactive oxygen species (ROS) accumulation, and enhanced MAPK phosphorylation. N-acetylcysteine (NAC) pretreatment reduced ROS levels and apoptotic cell fraction while partially restoring HSP27 expression. Boldine suppressed HSP expression-most notably HSP27-and attenuated HSF1 phosphorylation under hyperthermia. In NCI-N87 cells, confirmatory experiments showed higher apoptosis after cotreatment, whereas hyperthermia did not further reduce viability or alter HSP levels.
CONCLUSIONS: Boldine enhances hyperthermia-induced apoptosis in AGS gastric cancer cells in association with attenuation of the HSF1-HSP stress response and ROS accumulation, supporting boldine as a potential thermosensitizing adjunct in gastric cancer therapy.
METHODS AND RESULTS: AGS cells were pretreated with boldine (1 h) and exposed to 37-43 °C (30 min). Combined treatment reduced viability, wound closure, and colony formation more than single treatments. The apoptotic fraction increased from 8.08% in untreated controls to 28.79% with boldine alone and 3.55% with hyperthermia alone, reaching 46.33% after cotreatment. Cotreatment altered cell cycle distribution (S and G2/M fractions), increased reactive oxygen species (ROS) accumulation, and enhanced MAPK phosphorylation. N-acetylcysteine (NAC) pretreatment reduced ROS levels and apoptotic cell fraction while partially restoring HSP27 expression. Boldine suppressed HSP expression-most notably HSP27-and attenuated HSF1 phosphorylation under hyperthermia. In NCI-N87 cells, confirmatory experiments showed higher apoptosis after cotreatment, whereas hyperthermia did not further reduce viability or alter HSP levels.
CONCLUSIONS: Boldine enhances hyperthermia-induced apoptosis in AGS gastric cancer cells in association with attenuation of the HSF1-HSP stress response and ROS accumulation, supporting boldine as a potential thermosensitizing adjunct in gastric cancer therapy.